Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Supriya Lifescience Limited Call Transcript 2025

Jan 17, 2025

59375_rns_2025-01-17_239208a0-aa34-4047-a0b2-1c6c5477fee0.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [426 x 68] intentionally omitted <==

Date: January 17, 2025

To,

The Corporate Services Department, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 Scrip Code: 543434

Manager - Listing Department The National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex Bandra (E), Mumbai - 400 051 NSE Symbol: SUPRIYA

Dear Sir/Madam,

Subject: Intimation of Earnings Call for quarter and nine months ended December 31, 2024

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held on Monday, January 27, 2025 at 10.30 A.M. IST to discuss operational and financial performance of the Company for the quarter and nine months ended December 31, 2024. The invite giving requisite details including the pre-registration link and dial-in details is attached herewith.

This intimation is also being made available on the website of the Company at: - https://supriyalifescience.com/ir financial.php

Kindly take the information on record.

Thanking you,

For Supriya Lifescience Limited

Digitally signed by SHWETA SHIVDHARI SINGH SHWETA DN: c=IN, o=PERSONAL, pseudonym=5ed61118f9524963913aab8b2dd2f85 8, 2.5.4.20=7ecd6cc212b10d907bb2883c588d6eb1d1 SHIVDHARI f28d80e13dba2ebd6975df438869e5, postalCode=400097, st=Maharashtra, serialNumber=b696ab674736edaacabe9d4e9a63ae 406ea0e6dd83072b0cf6fa56593bffa9dd, SINGH cn=SHWETA SHIVDHARI SINGH Date: 2025.01.17 17:13:35 +05'30' Shweta Singh Company Secretary & Compliance Officer Membership No.: A44973

Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com

Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: [email protected]

GOVT. RECOGNISED EXPORT HOUSE

Supriya Lifescience Ltd

Cordially Invites you to Earnings call To discuss operational and financial performance for Q3 & 9M FY25

Monday, 27[th] Jan 2025 at 10:30 AM, IST Pre - Registration Link - Click Here

Management Representative:

▪ Dr. Satish Wagh – Executive Chairman & WTD

▪ Dr. Saloni Wagh – Managing Director

▪ Mr. Krishna Raghunathan - Chief Financial Officer

Access Numbers +91 22 6280 1550 Primary Number +91 22 7115 8378 Hongkong: 800 964 448 Singapore: 800 101 2045 International Toll Free Number USA: 1866 746 2133 UK: 0808 101 1573

RSVP : Mr. Prachi Ambre , Orient Capital - IR

Contact / Email : +91 83559 85370/ [email protected]